Libeksin Muco

Libexin Muco: Mucolytic agent for the treatment of diseases of the respiratory system

Libexin Muco is a mucolytic agent produced by the pharmaceutical company Sanofi Winthrop Industrie in France. The active component of the drug is carbocisteine, which is widely used to relieve symptoms of diseases of the respiratory system with copious and viscous bronchial secretions, as well as inflammatory diseases of the middle ear and paranasal sinuses. Libexin Muco is presented on the market in the form of syrup with an average carbocysteine ​​content of 5% and syrup for children with a content of 2%.

One of the key advantages of Libexin Muco is its ability to reduce the viscosity of bronchial secretions and promote their clearance, which helps ease breathing and reduce coughing. The drug is suitable for a wide range of patients and can be used in both adults and children.

However, before using Libexin Muco, it is necessary to take into account some contraindications. The drug is not recommended for use in case of hypersensitivity to carbocysteine, ulcerative lesions of the gastrointestinal tract, impaired renal function, acute glomerulonephritis, cystitis, as well as in case of pregnancy and breastfeeding. For syrup, the drug is not recommended for children under 1 year of age, and for granules - up to 16 years of age.

Libexin Muco may cause some side effects, including nausea, vomiting, epigastric pain, diarrhea, gastrointestinal bleeding and allergic reactions such as skin rash and angioedema. If you experience serious side effects, you should stop taking the drug and seek medical attention.

It is also important to consider possible interactions of Libexin Muco with other drugs. The drug increases the effectiveness of glucocorticoid and antibacterial therapy for inflammatory diseases of the upper and lower respiratory tract. It may also enhance the bronchodilator effect of theophylline. Some antitussives and atropine-like drugs, for example, may reduce the activity of carbocisteine.

In case of an overdose of Libexin Muco, symptoms such as epigastric pain, nausea and diarrhea may occur. If these symptoms occur, seek medical attention. Libexin Muco: A Mucolytic Agent for Respiratory System Disorders

Libexin Muco is a mucolytic agent manufactured by Sanofi Winthrop Industrie, a pharmaceutical company based in France. The active ingredient in the medication is carbocisteine, which is widely used to alleviate symptoms of respiratory system disorders with abundant and viscous bronchial secretions, as well as inflammatory conditions of the middle ear and nasal sinuses. Libexin Muco is available in the market as a syrup with an average carbocisteine ​​content of 5% and a children's syrup with a content of 2%.

One of the key advantages of Libexin Muco is its ability to reduce the viscosity of bronchial secretions and promote their clearance, which helps improve breathing and reduce coughing. The medication is suitable for a wide range of patients and can be used in both adults and children.

However, before using Libexin Muco, it is important to consider some contraindications. The medication is not recommended for individuals with hypersensitivity to carbocisteine, gastrointestinal ulcers, kidney function disorders, acute glomerulonephritis, cystitis, as well as during pregnancy and breastfeeding. The syrup formulation is not recommended for children under 1 year of age, and the granules are not recommended for individuals under 16 years old.

Libexin Muco may cause some side effects, including nausea, vomiting, epigastric pain, diarrhea, gastrointestinal bleeding, and allergic reactions such as rash and angioedema. If you experience severe side effects, it is important to discontinue the medication and seek medical attention.

It is also important to be aware of possible drug interactions with Libexin Muco. The medication enhances the effectiveness of glucocorticoid and antibacterial therapy for inflammatory disorders of the upper and lower respiratory tract. It can also potentiate the bronchodilatory effect of theophylline. Some antitussive and atropine-like medications, on the other hand, may diminish the activity of carbocisteine.

In case of overdose of Libexin Muco, symptoms such as epigastric pain, nausea, and diarrhea may occur. If these symptoms occur, it is important to seek medical assistance.